Cryoglobulins are proteins that form 'cloudy' precipitates at temperatures <37°C. In type I cryoglobulinemia, the causative protein is a monoclonal immunoglobulin due to an underlying plasma cell dyscrasia. Cryoglobulinemia can present with hyperviscosity syndrome, characterized by headache, fatigue, and blurred vision. In episodes of severe cryoglobulinemia, premature precipitation of proteins can lead to falsely negative diagnostic tests and complications with treatment. The following case exemplifies the complications of diagnosis and treatment of cryoglobulinemia with hyperviscosity syndrome.
Introduction
Plasma cell dyscrasias are associated with increased concentration of immunoglobulins, which may result in impaired microvascular circulation. Resultant symptoms are classified as hyperviscosity syndrome, including headache, confusion, dizziness, blurred vision, visual loss, epistaxis, and hearing loss. 2 The precipitation of these proteins at temperatures less than 37*C is termed as cryoglobulinemia. In the following case, the patient presented with extremely high immunoglobulin levels secondary to multiple myeloma. Premature precipitation of these proteins obscured the original diagnosis of cryoglobulinemia and its underlying etiology. Additionally, the high levels of immunoglobulins complicated the patient's treatment of hyperviscosity syndrome.
Case Report
A 79 year old man presented during the winter months with the chief complaint of syncope with positional lightheadedness. Additional symptoms included 4 months of fatigue, 15 pound unintentional weight loss, and bone pain. Physical exam was significant for cachexia, hypotension with sinus tachycardia. Complete blood count showed anemia (Hgb 11.8 x10 9 /L) with an elevated MCV (102.8 fL). A blood smear with Giemsa stain noted red blood cells in a classic rouleaux formation. Leukocyte count was 6.5 x10 9 /L with normal differential (Neutrophils 73%, Lymphocytes 18%, Monocytes 8%, Eosinophils 1%, Basophils 0%). Differential was without blasts or plasma cells. A basic metabolic panel noted an elevated creatinine (1.5 mg/dL) and elevated calcium (11.52 mg/dL).
Given the high suspicion for multiple myeloma, beta-2-microglobulin was ordered and found to be 4.61 mg/dL. Kappa:lambda free light chain ratio was found to be 0.031 (normal 0.26-1.65). Surprisingly, immunoglobulin levels were found to be within normal limits with IgA 76 mg/dL (normal 85-499mg/dL), IgG 1525 mg/dL (normal 610-1616 mg/dL), and IgM 29 mg/ dL (normal 35-242 mg/dL). A working diagnosis of light chain myeloma was proposed due to the isolated elevation in lambda light chains.
The patient continued to display positional lightheadedness, hypotension, and symptoms of presyncope including blurred vision, muscular weakness, and feeling faint. Hyperviscosity syndrome due to type 1 cryoglobulinemia was suggested. Serum viscosity was found to be 3 (normal <1.5 centipoise). Due to the rarity of hyperviscosity syndrome in pure light chain myelomas, repeat immunoglobulin levels were drawn. On inspection of the patient's serum, the cryoprecipitate was clearly visible at temperatures >37°C (Fig 1) , and it was ascertained initial immunoglobulin levels were not appropriately measured. A repeat sample was drawn in a prewarmed tube with caution to prevent premature precipitation of cryoglobulins. Repeat IgG level was found to be 7322 mg/dL. A preliminary diagnosis of IgG lambda multiple myeloma was made with confirmation on bone marrow biopsy. cryoglobulinemia was initiated with plasmapheresis. Unfortunately, initial attempts at plasmapheresis were unsuccessful due to premature precipitation of cryoglobulins in the catheter. Measures to prevent line occlusion were implemented including infusion of warming fluids, placement of warming blankets, and administration of dexamethasone 10mg IV daily. With these adjunctive therapies, the patient was able to undergo 4 rounds of plasmapheresis with reduction of IgG levels to 1002 mg/dL. Patient reported resolution of pre-syncopal symptoms and normalization of blood pressure was observed. The patient was started on bortezomib with dexamethasone to treat the underlying multiple myeloma with excellent response. Currently he is alive and disease free approximately 2 years from the initial encounter.
Discussion
Normal plasma viscosity is dictated by the content and concentration of proteins present. Proteins such as immunoglobulins with higher molecular weight and greater degree of asymmetry result in greater plasma viscosity. Due to the pathologic levels of immunoglobulins required for symptoms, it is unsurprising that hyperviscosity syndrome is often observed in type I cryoglobulinemia but only in <3% of mixed cryoglobulinemias. 4 Of the plasma cell dyscrasias, hyperviscosity syndrome has been noted in 10-30% of Waldenstrom's Macrolgobulinemia (WM) and only 2-6% of multiple myeloma. 5, 6 This may be explained by the contribution of large, asymmetrical immunoglobulin polymers to increased serum viscosity. WM produces monoclonal IgM that forms large, asymmetric pentamers and would more likely result in higher serum viscosity. When hyperviscosity syndrome is observed in multiple myeloma, it is usually due to the formation of IgA or IgG polymers. 7, 8 Light chain myeloma is rarely associated with hyperviscosity syndrome, likely due to its smaller molecular size. 8, 9, 10 In case reports of light chain myeloma hyperviscosity syndrome, highly polymerized kappa light chains have been found. 10 Though the polymerization status of this patient is unknown, the lambda light chain component of his myeloma makes it less likely that this would present with hyperviscosity syndrome.
Measurement of immunoglobulins involved in hyperviscosity syndrome can be complicated by precipitation as seen in this case. At extremely high concentrations, premature precipitation of immunoglobulins at temperatures greater than 37°C Case Report | WVMJ OA In this case, a prewarmed tube was used and directly transported to the lab in order to obtain accurate measurements. Acute treatment of hyperviscosity targets the alleviation of symptoms through plasmapheresis. Viscosity is logarithmically related to protein levels, therefore even a mild decrease in plasma levels of immunoglobulin can result in significant symptom relief.
5 This case reports unique complications to plasmapheresis in the setting of severe cryoglobulinemia due to clotting of the catheter at temperatures >37°C. In such settings, we have found that using warming fluids as well as warming the patient's core temperature with steroid usage was effective in completing plasmapheresis.
Of note, this patient began to exhibit symptoms of hyperviscosity related to type 1 cryoglobulinemia during the winter months. It may be that colder environmental temperatures precipitated plasma proteins resulting in cryoglobulinemia. Patients at risk for elevated immunoglobulin levels should be counseled on the importance of maintaining a warm environment to avoid symptoms of cryoglobulinemia.
Conclusion
This case emphasizes the importance of considering hyperviscosity syndrome secondary to type 1 cryoglobulinemia in the differential diagnosis of presyncopal symptoms or syncope. When collecting diagnostic samples for cryoglobulinemia, appropriate warming techniques should be observed to ensure premature precipitation does not occur. Finally, patients with elevated immunoglobulin states should be counseled on the importance of maintaining a warm environment in order to prevent symptoms and aid treatment of cryoglobulinemia.
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